DUBE ERIC M (Chief Executive Officer) sold 12.2% of their position (60K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.86M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/2/2026ACC: 0001763494-26-000004
DirectorOfficer· Chief Executive Officer
Since Jan 2019
-60K
Net shares
Net seller
$1.86M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+60K
Price / share
$15.46
Trade value
$927.60K
% of position
13.9%
4/1/2026
432.89K→492.89K
Common Stock
Direct
Shares
−34.90K
Price / share
$30.55
Trade value
$1.07M
% of position
7.1%
4/1/2026
492.89K→457.98K
Common Stock
Direct
Shares
−25.10K
Price / share
$31.46
Trade value
$789.58K
% of position
5.5%
4/1/2026
457.98K→432.89K
Total
Net shares
+0.00
Net value
-$928.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +60K | $15.46 | $927.60K | 13.9% | 432.89K | 492.89K |
| Common Stock Direct | 4/1/2026 | S · Sale | −34.90K | $30.55 | $1.07M | 7.1% | 492.89K | 457.98K |
| Common Stock Direct | 4/1/2026 | S · Sale | −25.10K | $31.46 | $789.58K | 5.5% | 457.98K | 432.89K |
| Total | +0.00 | -$928.24K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
60K shares
Shares
−60K
Strike price
15.46
Held after
0.00
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock60K shares | 4/1/2026 | M · Option Exercise | −60K | 15.46 | — | 0.00 |